Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Polpharma Biologics International AG
Entity

Polpharma Biologics International AG

Tracked across 1 events · 14 articles · First seen Jul 09, 2026 · Last active Jul 09, 2026

Sentiment
20
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 20
Business
Teva-Polpharma Ocrevus biosimilar licensing deal
Impact: Polpharma Biologics grants Teva a global license, leveraging Teva's commercial footprint while retaining development and manufacturing responsibilities.
Jul 09, 2026 · 14 articles
ERGEN INTELLIGENCE
Track Polpharma Biologics International AG live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.